Add To Watchlist
Share URL
About The Company
CEO
Mr. Stephen Bradley Saad
Market Cap
66.31 Billion ZAc
Sector
Healthcare
Website
https://www.aspenpharma.comDescription
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide.
Read More
Overview
Value
18
Growth
12
Health
43
Management
24
Analyst Opinion
0
Total
24
All Scores Out Of 100
Best Features
- Has a low level of debt
- Has a history of share buybacks
- Has strong dividend growth
- Low preportion of income is paid as dividend
- Dividend could be at risk
Risk Factors
- Overvalued on cashflow basis
- Earnings growth has slowed down recently
- Poor earnings and cashflow growth
Market Peers
APN.JO
Key Figures
PE Ratio (TTM)
N/A
Margin Of Safety (DCF)
19.33%
Revenue Growth (5 Year Average)
-0.58%
Ratings Consensus
N/A
Share Buybacks
0.19%
Dividend Yeild (TTM)
N/A
Valuation
Value Score
18
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Buy Target: < 15819.7 ZAc ✔
Current Price: 14952 ZAc
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.
Price/Earnings
N/Ax
Free Cashflow Yeild
N/A
PE/Earnings Growth
N/A
Price/Book
0.95x
Growth
Growth Score
12
- ✔ Revenue growth has improved this yeara
- ✔ Free Cashflow growth has improved this year
- ✘ 5 Year Average Revenue growth of -0.58% is lower than the market average (10.97%)
- ✘ 5 Year Average Earnings growth of 7.54% is lower than the market average (14.48%)
- ✘ Earnings growth has slowed this year
- ✘ 5 Year Average Free Cashflow growth of -16.23% is lower than the market average (12.35%)
Revenue Growth
-0.58%
Earnings Growth
7.54%
Cashflow Growth
-16.23%
Health
Health Score
43
Altman Z Score
N/A
Piostroski Score
N/A
Debt/Equity
0.31x
Current Assets/Liabilities
1.48x
Free Cashflow/Total Debt
0.12x
Debt/Capital
0.64x
Dividend
Secure Dividend Score
25
- ✔ Long term dividend payout ratio of 12.50% is considered good
- ✔ Payout ratio (TTM) of N/A is lower than the average (40%)
- ✔ Dividends have shown growth over the last 5 years
- ✔ Spending a lower percentage of their income on dividends than last 5 years
- ✘ Dividend yeild of N/A is less than the market average (1.85%)
- ✘ Very unsafe
- ✘ Dividend growth has been slowing recently
Dividend Yeild
N/A
Dividend Growth
N/A
Payout Ratio (Earnings)
N/A
Payout Ratio (Cashflow)
N/A
Management
Management Score
24
- ✔ Has a history of returning value to shareholders through stock buybacks
- ✔ Has returned higher dividends when earnings have risen
- ✘ Return-on-capital-employed of 9.15% is lower than the market average (10%)
- ✘ Has repurchased shares when overvalued
- ✘ Return-on-equity of 0.09% is lower than the market average (15%)
Average Buybacks/Dilution
0.19%
Recent Buybacks/Dilution
-99.01%
5 Year Price Volitility
33.68%
Return On Assets
0.06%
Return On Capital Employed
9.15%
Return On Equity
0.09%
Return On Free Cashflow
1.90%
Return On Investments
N/A
Analysts
Analyst Opinion
0
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
Other Information
Company Name
Aspen Pharmacare Holdings Limited
Currency
ZAc
Beta
0.586012
Vol Avg
890393
Ceo
Mr. Stephen Bradley Saad
Cik
Cusip
Exchange
Johannesburg
Full Time Employees
8580
Industry
Drug Manufacturers—Specialty & Generic
Sector
Healthcare
Ipo Date
2000-01-04
Address
Aspen Place
City
Durban
State
Country
ZA
Zip
Phone
27 31 580 8600
All financial data provided by FMP